News

Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...
Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...
Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.
A 5-year-old boy with a neuroblastoma developed PAH after receiving a high dose of chemotherapy to prepare for a stem cell transplant.